Tue Sep 10 16:17:00 UTC 2024: Please provide me with the text you would like me to summarize and rewrite as a news article. I need the text content to complete your request.
Eli Lilly’s Once-Weekly Insulin Treatment Meets Primary Endpoint in Qwint-2 Phase 3 Trial
Eli Lilly's Once-Weekly Insulin Treatment Meets Primary Endpoint in Qwint-2 Phase 3 Trial
First Piper 